Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12576201 | Methods for isolating umbilical cord blood plasma products, tissue and cellular exosomes, and compositions and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-11-25 | 0 | 31 |
| 12576115 | Bacterial compositions for treating and preventing halitosis | 🖼🧊📄§ | 2026-03-17 | 2044-09-13 | 0 | 31 |
| 12576116 | Use of probiotics in the treatment and/or prevention of atopic dermatitis | 🖼🧊📄§ | 2026-03-17 | 2037-07-18 | 0 | 31 |
| 12576117 | Antiviral agent | 🖼🧊📄§ | 2026-03-17 | 2041-05-28 | 0 | 31 |
| 12576111 | Application of BMSC-exos in treating PD | 🖼🧊📄§ | 2026-03-17 | 2042-10-19 | 0 | 31 |
| 12576113 | Rotator cuff therapy using muscle fiber fragments | 🖼🧊📄§ | 2026-03-17 | 2040-10-26 | 0 | 31 |
| 12576112 | Inhibition of TNF-alpha by fibroblasts and fibroblast exosomes | 🖼🧊📄§ | 2026-03-17 | 2040-12-22 | 0 | 31 |
| 12576107 | Methods of treating chronic inflammatory diseases | 🖼🧊📄§ | 2026-03-17 | 2043-09-11 | 0 | 31 |
| 12576110 | Methods and compositions for reconstituting microglia | 🖼🧊📄§ | 2026-03-17 | 2040-08-06 | 0 | 31 |
| 12576108 | Compositions comprising hyper harmonized hydroxyl modified fullerene substances | 🖼🧊📄§ | 2026-03-17 | 2039-12-02 | 0 | 31 |
| 12576109 | Allogeneic human plasma and platelet derived products and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2045-04-30 | 0 | 31 |
| 12576105 | Compositions for treating joint or connective tissue disease comprising dextran or poloxamer | 🖼🧊📄§ | 2026-03-17 | 2043-10-05 | 0 | 31 |
| 12576099 | Ribose-modified cap analog and use thereof | 🖼🧊📄§ | 2026-03-17 | 2045-02-28 | 0 | 31 |
| 12576103 | Heparin and N-acetylcysteine for the treatment of lung injury | 🖼🧊📄§ | 2026-03-17 | 2041-03-19 | 0 | 31 |
| 12576101 | Application based nucleotides of Lactobacillus rhamnosus to prepare a composition for anti-lipogenesis | 🖼🧊📄§ | 2026-03-17 | 2044-05-29 | 0 | 31 |
| 12576102 | Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability | 🖼🧊📄§ | 2026-03-17 | 2043-03-10 | 0 | 31 |
| 12576092 | Pharmaceutical suspensions for bismuth subsalicylates | 🖼🧊📄§ | 2026-03-17 | 2043-04-19 | 0 | 31 |
| 12576090 | Oral brexanolone compositions and methods of preparation and use | 🖼🧊📄§ | 2026-03-17 | 2044-11-18 | 0 | 31 |
| 12576096 | Topical, isotonic compositions for genital use | 🖼🧊📄§ | 2026-03-17 | 2041-06-09 | 0 | 31 |
| 12576091 | Preparation method of salfaprodil freeze-dried powder injection, and product and use thereof | 🖼🧊📄§ | 2026-03-17 | 2041-07-27 | 0 | 31 |
| 12576088 | Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B | 🖼🧊📄§ | 2026-03-17 | 2043-09-15 | 0 | 31 |
| 12576089 | Platelet count-agnostic methods of treating myelofibrosis | 🖼🧊📄§ | 2026-03-17 | 2044-03-12 | 0 | 31 |
| 12576084 | Methods for treating testicular and ovarian adrenal rest tumors | 🖼🧊📄§ | 2026-03-17 | 2045-01-31 | 0 | 31 |
| 12576087 | Aryloxypiperidine pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors | 🖼🧊📄§ | 2026-03-17 | 2039-08-16 | 0 | 31 |
| 12576086 | Aqueous composition, in particular for treating mucosa and/or wounds | 🖼🧊📄§ | 2026-03-17 | 2039-10-23 | 0 | 31 |
| 12576082 | METTL16 inhibitors and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-08-20 | 0 | 31 |
| 12576080 | Use of varenicline for treating ocular conditions | 🖼🧊📄§ | 2026-03-17 | 2045-04-03 | 0 | 31 |
| 12576076 | Use of HSP70 as a regulator of enzymatic activity | 🖼🧊📄§ | 2026-03-17 | 2044-02-19 | 0 | 31 |
| 12576078 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 🖼🧊📄§ | 2026-03-17 | 2045-04-17 | 0 | 31 |
| 12576014 | Personal care composition with visually distinct aqueous and oil phase | 🖼🧊📄§ | 2026-03-17 | 2041-04-20 | 0 | 31 |
| 12576016 | Composition containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a preservative and/or antioxidant, a surfactant and a polymer, and the method for processing keratin materials from the composition | 🖼🧊📄§ | 2026-03-17 | 2040-12-02 | 0 | 31 |
| 12576012 | Surface-modified zinc oxide particles, dispersion solution, and cosmetic | 🖼🧊📄§ | 2026-03-17 | 2040-04-30 | 0 | 31 |
| 12576020 | Increasing the stability of agents for the treatment of keratinous material | 🖼🧊📄§ | 2026-03-17 | 2040-02-05 | 0 | 31 |
| 12576021 | Method of making and using a skin moisturizing formulation | 🖼🧊📄§ | 2026-03-17 | 2041-06-18 | 0 | 31 |
| 12576019 | Personal cleansing composition with an organic acid having a pKa greater than 2.7 | 🖼🧊📄§ | 2026-03-17 | 2042-10-28 | 0 | 31 |
| 12576018 | Active agents for skin and hair care with sensory modifying properties | 🖼🧊📄§ | 2026-03-17 | 2039-02-04 | 0 | 31 |
| 12576026 | Formulations of nebivolol | 🖼🧊📄§ | 2026-03-17 | 2041-07-08 | 0 | 31 |
| 12576028 | Pharmaceutical or nutraceutical self-emulsifying solid dispersion composition | 🖼🧊📄§ | 2026-03-17 | 2043-01-18 | 0 | 31 |
| 12576029 | Noncompetitive receptor-targeted vaccine delivery to plasmacytoid dendritic cells | 🖼🧊📄§ | 2026-03-17 | 2043-07-12 | 0 | 31 |
| 12576025 | Pharmaceutical parenteral composition of dual GLP1/2 agonist | 🖼🧊📄§ | 2026-03-17 | 2040-06-12 | 0 | 31 |
| 12576027 | Diclofenac topical formulation with a high absorption rate | 🖼🧊📄§ | 2026-03-17 | 2042-06-22 | 0 | 31 |
| 12576034 | Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione | 🖼🧊📄§ | 2026-03-17 | 2040-05-14 | 0 | 31 |
| 12576035 | Polymeric implants with high drug loading and long-acting drug release and methods of making the same | 🖼🧊📄§ | 2026-03-17 | 2040-01-31 | 0 | 31 |
| 12576032 | Liquid clonidine extended release composition | 🖼🧊📄§ | 2026-03-17 | 2044-01-23 | 0 | 31 |
| 12576039 | Lipid-polymer compositions and methods of use | 🖼🧊📄§ | 2026-03-17 | 2041-05-18 | 0 | 31 |
| 12576038 | Composition, lipid particle manufacturing kit, substance delivery method, and detection method | 🖼🧊📄§ | 2026-03-17 | 2041-09-10 | 0 | 31 |
| 12576044 | Treatment of Alzheimer's disease | 🖼🧊📄§ | 2026-03-17 | 2043-05-03 | 0 | 31 |
| 12576046 | Aqueous paediatric retinol formulations | 🖼🧊📄§ | 2026-03-17 | 2039-11-26 | 0 | 31 |
| 12576048 | Anti-cancer activity of adamantane derivatives | 🖼🧊📄§ | 2026-03-17 | 2039-12-05 | 0 | 31 |
| 12576047 | Telomerase activating compounds for use in fertility and related applications | 🖼🧊📄§ | 2026-03-17 | 2043-08-25 | 0 | 31 |